Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidine

scientific article published on 01 June 2006

Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.21905
P698PubMed publication ID16649225

P50authorNaohiko SekiQ90079422
P2093author name stringOsamu Yokosuka
Tatsuo Kanda
Makoto Arai
Takenori Ochiai
Hiromitsu Saisho
Tetsuhiro Chiba
Fumio Imazeki
Yuichi Takiguchi
Mari Yatomi
Kenichi Fukai
Yuichi Hirasawa
P2860cites workMicrotubules as a target for anticancer drugsQ28253993
Gene silencing in cancer in association with promoter hypermethylationQ29617274
Cancer epigenetics comes of ageQ29617275
FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genesQ29618118
Comparing gene expression profiles in human liver, gastric, and pancreatic tissues using full-length-enriched cDNA librariesQ30980292
Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cellsQ34124417
DNA methylation, chromatin inheritance, and cancerQ34290318
The prognostic molecular markers in hepatocellular carcinomaQ34668320
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapyQ34770609
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastomaQ35103214
Tumor cell invasion and survival in head and neck cancerQ36078087
Number of CpG islands and genes in human and mouseQ36738077
Gene expression profiles in liver regeneration with oval cell induction.Q38342825
Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma.Q40447611
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylateQ40508930
Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancerQ40543809
Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cellsQ41070371
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatmentQ44155422
Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathwayQ44512459
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignanciesQ44646952
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathwayQ45215124
p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infectionQ45659545
Identification and investigation of methylated genes in hepatomaQ46505315
Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regenerationQ73469397
Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survivalQ73847008
P433issue11
P304page(s)2514-2525
P577publication date2006-06-01
P1433published inCancerQ326041
P1476titleSequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2'-deoxycytidine
P478volume106

Reverse relations

cites work (P2860)
Q458983015-AZA-2'-deoxycytidine (5-AZA-CdR) leads to down-regulation of Dnmt1o and gene expression in preimplantation mouse embryos.
Q344288775-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes
Q37035513Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment
Q35121612DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer
Q48009718GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
Q36412740Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species

Search more.